You just read:

Elysium Health™ Raises $20 Million In Series B Financing Led By General Catalyst, Announces Topline Clinical Trial Results For Its First Product BASIS™, And Welcomes Leading Scientists And Physicians To Its Scientific Advisory Board

News provided by

Elysium Health

Dec 06, 2016, 15:00 ET